Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AZD0292 in Bronchiectasis With Pseudomonas Aeruginosa Colonization
NCT07088926Phase 2Recruiting
- Sponsor
- AstraZeneca
- Start
- Nov 2025
- Primary completion
- Dec 2027
- Countries
- 25
01
Overview
A Phase 2 trial of AZD-0292 in bronchiectasis, sponsored by AstraZeneca. Started Nov 2025; status: recruiting.
02
Drugs
AZD-0292
03
Conditions
bronchiectasis
Beyond the preview
Go deeper on NCT07088926.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07088926.